AVTX Financials
Avalo Therapeutics Inc - Financial statements & key metrics
Stock Price
$19.14
Market Cap
$51.54M
P/E Ratio
0.0
EPS
$-13.42
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$441,000
Gross Profit
-
Operating Income
-
Net Income
$-35.13M
EPS (Diluted)
$-20.91
Balance Sheet Highlights
Total Assets
$150.73M
Total Liabilities
$17.70M
Shareholders Equity
-
Cash & Equivalents
$134.55M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-49.06M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-34632.3%
ROE
-174.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AVTX revenue?
AVTX's most recent quarterly revenue was $441,000. Annual revenue can be calculated by summing the four most recent quarters.
Is AVTX profitable?
AVTX reported a loss of $35.13M in the most recent quarter.
What is AVTX market cap?
AVTX has a market capitalization of $51.54M, making it a small-cap stock.
Does AVTX have debt?
View AVTX's balance sheet for debt information.
What is AVTX cash flow?
Cash flow data is available in the full financial statements.